Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8126
authID Inc
AUID
$5.85M
| $16 | ﹤0.01% |
+15
| New | +$18 |
2026 Q2
0 quarters
|
|
8127
IT Tech Packaging
ITP
$2.58M
| $16 | ﹤0.01% |
+88
| New | +$17 |
2026 Q2
0 quarters
|
|
8128
Global X NASDAQ 100 Risk Managed Income ETF
QRMI
$14.5M
| $16 | ﹤0.01% |
+1
| New | +$15 |
2026 Q2
0 quarters
|
|
8129
CoinShares Bitcoin and Ether ETF
BTF
$15.8M
| $15 | ﹤0.01% |
+1
| New | +$19 |
2026 Q2
0 quarters
|
|
8130
AltShares Event-Driven ETF
EVNT
$13.1M
| $15 | ﹤0.01% |
1
| – | – |
2025 Q4
2 quarters
|
|
8131
Hennessy Advisors
HNNA
$80.5M
| $15 | ﹤0.01% |
1
| – | – |
2025 Q4
2 quarters
|
|
8132
Mannatech
MTEX
$15.2M
| $15 | ﹤0.01% |
2
| – | – |
2021 Q3
19 quarters
|
|
|
OKYO
8133
OKYO Pharma
OKYO
$74.5M
| $15 | ﹤0.01% |
10
| – | – |
2025 Q4
2 quarters
|
|
|
SCNI
8134
Scinai Immunotherapeutics
SCNI
$800K
| $15 | ﹤0.01% |
6
| – | – |
2020 Q2
24 quarters
|
|
|
CTOR
8135
Citius Oncology
CTOR
$88.8M
| $15 | ﹤0.01% |
+23
| New | +$18 |
2026 Q2
0 quarters
|
|
|
MWYN
8136
Marwynn Holdings
MWYN
$27.7M
| $15 | ﹤0.01% |
+14
| New | +$12 |
2026 Q2
0 quarters
|
|
|
BCCC
8137
Global X Bitcoin Covered Call ETF
BCCC
$9.27M
| $15 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
8138
GraniteShares HIPS US High Income ETF
HIPS
$103M
| $14 | ﹤0.01% |
1
| – | – |
2025 Q2
4 quarters
|
|
|
XHG
8139
XChange TEC
XHG
$118M
| $14 | ﹤0.01% |
15
| – | – |
2025 Q2
4 quarters
|
|
|
MTVA
8140
MetaVia Inc
MTVA
$9.29M
| $14 | ﹤0.01% |
+10
| New | +$18 |
2026 Q2
0 quarters
|
|
8141
Celularity
CELU
$50.6M
| $13 | ﹤0.01% |
21
+20
| +2,000% | +$19 |
2026 Q1
1 quarter
|
|
8142
Direxion Daily Real Estate Bull 3X ETF
DRN
$36.5M
| $13 | ﹤0.01% |
1
| – | – |
2023 Q1
13 quarters
|
|
|
EVGOW
8143
DELISTED
EVgo Inc Warrants
EVGOW
| $13 | ﹤0.01% |
1,450
| – | – |
2024 Q3
7 quarters
|
|
8144
Femasys
FEMY
$16.8M
| $13 | ﹤0.01% |
+3
| New | +$21 |
2026 Q2
0 quarters
|
|
8145
FMQQ The Next Frontier Internet & Ecommerce ETF
FMQQ
$20.4M
| $13 | ﹤0.01% |
1
| – | – |
2025 Q2
4 quarters
|
|
|
CRCO
8146
YieldMax CRCL Option Income Strategy ETF
CRCO
$31.2M
| $13 | ﹤0.01% |
+1
| New | +$21 |
2026 Q2
0 quarters
|
|
8147
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$114M
| – | – |
0
| – | – |
2025 Q4
2 quarters
|
|
8148
Hoya Capital High Dividend Yield ETF
RIET
$99M
| $12 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
8149
Vivani Medical
VANI
$113M
| $12 | ﹤0.01% |
10
-331
| -97% | -$400 |
2014 Q4
46 quarters
|
|
|
CELG.RT
8150
Bristol-Myers Squibb Rights
CELG.RT
$242M
| $11 | ﹤0.01% |
119
| – | – |
2019 Q4
26 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.